Pella J, Bodnár J, Stancák B, Misíkoá S, Sedlák J, Cizmárik P
II. interná klinika FN L. Pasteura Univerzity P. J. Safárika, Kosice.
Vnitr Lek. 1994 Oct;40(10):663-6.
The administration of an implantable cardioverter-defibrillator (ICD) is the method of choice in life-threatening ventricular tachyarrhythmias. This effective non-pharmacological intervention was a great advance in the prevention of sudden cardiac death. As to ventricular tachycardias, relapsing ventricular tachycardias based on ischaemic alone need not influence ventricular tachycardia. The mechanism of ventricular tachycardia in ischaemic heart disease is reentry and therefore this arrhythmia can be terminated not only by a defibrillation discharge but also by antitachycardiac stimulation. Various types of antitachycardiac stimulation are part of modern types of ICD. Evidence of the effectiveness of antitachycardiac stimulation (electrophysiological examination) permits to use it also by the transoesophageal approach. This treatment can be very effective and we can thus overcome the period before the definite administration of an ICD, as indicated by the case described.
植入式心脏复律除颤器(ICD)的应用是治疗危及生命的室性快速心律失常的首选方法。这种有效的非药物干预措施在预防心源性猝死方面是一项重大进展。至于室性心动过速,仅基于缺血的复发性室性心动过速不一定会影响室性心动过速。缺血性心脏病中室性心动过速的机制是折返,因此这种心律失常不仅可以通过除颤放电终止,也可以通过抗心动过速刺激终止。各种类型的抗心动过速刺激是现代ICD的组成部分。抗心动过速刺激有效性的证据(电生理检查)使得经食管途径也可使用该方法。这种治疗可能非常有效,因此我们可以如所描述的病例所示,在确定植入ICD之前的这段时间内克服困难。